Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+2.65%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$191B
AUM Growth
-$14.1B
Cap. Flow
-$5.18B
Cap. Flow %
-2.71%
Top 10 Hldgs %
39.72%
Holding
509
New
37
Increased
114
Reduced
204
Closed
17

Top Sells

1
BABA icon
Alibaba
BABA
$2.33B
2
TSLA icon
Tesla
TSLA
$1.55B
3
MRNA icon
Moderna
MRNA
$1.41B
4
AMZN icon
Amazon
AMZN
$884M
5
NTES icon
NetEase
NTES
$692M

Sector Composition

1 Consumer Discretionary 27.71%
2 Healthcare 26.02%
3 Technology 19.32%
4 Communication Services 12.04%
5 Financials 4.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ATRI
476
DELISTED
Atrion Corp
ATRI
$6K ﹤0.01%
9
AI icon
477
C3.ai
AI
$2.15B
$5K ﹤0.01%
117
FGEN icon
478
FibroGen
FGEN
$48.9M
$5K ﹤0.01%
19
FOLD icon
479
Amicus Therapeutics
FOLD
$2.46B
$5K ﹤0.01%
538
ZYXI icon
480
Zynex
ZYXI
$45.1M
$5K ﹤0.01%
481
AGX icon
481
Argan
AGX
$2.92B
$4K ﹤0.01%
103
CVGW icon
482
Calavo Growers
CVGW
$485M
$4K ﹤0.01%
113
HCSG icon
483
Healthcare Services Group
HCSG
$1.15B
$4K ﹤0.01%
157
QTTB icon
484
Q32 Bio
QTTB
$20.4M
$4K ﹤0.01%
27
AFIB
485
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
$4K ﹤0.01%
424
HRTX icon
486
Heron Therapeutics
HRTX
$201M
$3K ﹤0.01%
308
AMRX icon
487
Amneal Pharmaceuticals
AMRX
$3.02B
$2K ﹤0.01%
452
AXDX
488
DELISTED
Accelerate Diagnostics
AXDX
$2K ﹤0.01%
42
PBYI icon
489
Puma Biotechnology
PBYI
$253M
$2K ﹤0.01%
252
EAR
490
DELISTED
Eargo, Inc. Common Stock
EAR
$2K ﹤0.01%
13
ICPT
491
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
101
AAOI icon
492
Applied Optoelectronics
AAOI
$1.45B
-260
Closed -$2K
CMPR icon
493
Cimpress
CMPR
$1.54B
-84
Closed -$9K
EOG icon
494
EOG Resources
EOG
$64.4B
-3,939,421
Closed -$329M
GRFS icon
495
Grifois
GRFS
$6.89B
-2,948,016
Closed -$51.1M
HEI icon
496
HEICO
HEI
$44.8B
-179,346
Closed -$25M
HEI.A icon
497
HEICO Class A
HEI.A
$35.1B
-1,653,301
Closed -$205M
HRL icon
498
Hormel Foods
HRL
$14.1B
-264
Closed -$13K
IQ icon
499
iQIYI
IQ
$2.61B
-2,552,975
Closed -$39.8M
JAGX icon
500
Jaguar Health
JAGX
$3.85M
$0 ﹤0.01%
18
+12
+200%